VECTION CONTINUES SECOND HALF MOMENTUM

VECTION ACHIEVES ~300% GROWTH IN SECOND HALF CLIENT ORDERS

Highlights: 

• ~300% increase in second half clients orders to date to ~$2.1M (First half revenue $740k)
•  Second half clients include Volkswagen, Trenitalia, Olivetti TIM Group, Unopiù, CompuGroup Medical (CGM), DELL Platinum and OEM Partner, JMC Group, the Chinese University of Hong Kong and Armani, among others
• Launch of Vection Healthcare & Pharma vertical and strong advancement on overarching building blocks
•  Pandemic-led extended E.U. client payment terms resulting in ~$1M in debtors at quarter end, not represented in the quarterly cash receipts
•  Strong cash balance of ~$6.1M enables the Company to pursue it growth objectives and aggressive M&A strategy from a position of strength
•  Strong focus on the Digital Transformation (DX) trend, also supported by the ~$1.2 trillion NextGen European Recovery plan, including $51 billion for DX in Italy and ~$230 billion across Europe
•  Investor call to be held on Tuesday 4 May 2021 at 12pm AEST

.....Investor Presentation and Call:

Vection’s management will host a conference call on Tuesday 4 May 2021 at 12pm AEST to discuss the investor presentation (slides to be released separately to the market on Monday 3 May 2021) and to provide an update of the Company’s business strategy and financial performance. Participants must register in advance for the investor call using the following link to receive dial-in details: https://zoom.us/webinar/register/WN_g5cGX5HTTnmxSpWdVVQxWg After registering, you will receive a confirmation email containing information about joining the webinar.

DISC: Small holding

11/3/21   LAUNCH OF HEALTHCARE & PHARMA SOLUTIONS VERTICAL

FIRST MILESTONE IN THE 2021 VERTICALIZATION STRATEGY

Highlights:

•  Vection strongly accelerates its international growth strategy with the launch of its Healthcare & Pharma Solutions Division
•  Vection joins forces with highly experienced team with former roles in BASF, Knoll Pharmaceuticals, Abbott Laboratories, Bristol-Myers Squibb, AstraZeneca, Novartis, Boehringer Ingelheim and Dompé Farmaceutici
•  Strong commitment by the executive team with joint division ownership and strong opportunities pipeline anticipated to come to fruition from April 2021
•  Strong ability to attract senior industry-specific executives key for the Company’s growth acceleration
•  Expansion of Vection’s footprint in the healthcare, pharmaceutical, biotechnological, medical devices and nutraceutical market segments leveraging its existing core technology stack
•  Strategic division for continued growth during the current pandemic aligned with the digital transformation trend in healthcare
•  First milestone in the 2021 Verticalization strategy achieved
•  A brief presentation of the Healthcare & Pharma Solutions division is appended to this announcement

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02352337-6A1024054?access_token=83ff96335c2d45a094df02a206a39ff4       ...also includes small presentation

19/3/21     ADDITIONAL INFORMATION ON THE HEALTHCARE & PHARMA DIVISION

Further the announcement dated 11 March 2021, the Company provides the following additional information:

•  Following extensive negotiations, the Company has secured the strong commitment of Dr Centemeri through the incorporation of a joint venture company controlled by Vection at 60%, with 40% owned by Dr Centemeri (Division), a leading healthcare and pharma executive with senior experience in BASF, Knoll Pharmaceuticals, Abbott Laboratories, Bristol-Myers Squibb and AstraZeneca.
•  The key terms of the agreement with Dr Centemeri consist of his involvement in the new Division and his commitment as its Managing Director, to the achievement of expansion of Vection’s footprint in the healthcare, pharmaceutical, biotechnological, medical devices and nutraceutical market segments as disclosed, which forms the basis of a comprehensive results driven business plan which is an integral part of his commitment.
•  Vection will provide funding for establishment costs of the Division pursuant to a comprehensive business plan underpinned by the commitment of Dr Centemeri. The initial agreement provides for the commitment of Dr Centemeri, the composition of the new Division, exclusivity, non-competition, business plan and cash flows and activities of the new company.
•  Vection controls the new Division on the basis of holding a 60% shareholding and retaining control of its board. The board composition is Dr Centemeri and 2 appointees of Vection.

see attached

Disc: Small holding

VECTION TECHNOLOGIES COLLABORATES WITH HP INC.

Real-time software company Vection Technologies (ASX:VR1) (Vection Technologies, Vection or the Company) is pleased to announce the execution of an Original Equipment Manufacturer (OEM) agreement with multinational technology company HP Inc (HP) 

The OEM collaboration will play a critical role inthe delivery of Virtual Reality (VR) integrted solutions (HP's VR hardware & Vections VR software) in over 170 countries via HP's g;obal network. This agreemen follows on from the entry of Vection's Mindesk in the HP Independant Software Vendor Partner Program:Virtual Reality tracking during August 2019.

Disc: I have a small holding

Real-time software company Vection Technologies Ltd (ASX:VR1) (Vection Technologies, Vection or the Company) is pleased to announce the launch of an innovative Augmented and Mixed reality (XR) interface for Computer Aided Design (CAD) software released with the latest Mindesk Suite 2021, during the most influential tech event in the world, the CES® 2021. CES® 2021,

The World’s Biggest Annual Consumer Electronics Show Vection Technologies will be officially launching its breakthrough Mindesk release at the world’s biggest annual consumer electronics show, the CES® 2021, an all-digital experience where the biggest names in the industry will be sharing their latest and greatest innovations online via the organisers media hub. CES® 2021 will officially take place from Monday 11th to Thursday 14th January 2021

An example video of Mindesk Suite 2021 integration with Varjo XR1 is available at the following link: https://youtu.be/6zs2wEfeeJQ

DISC: Another small holding